| Title | Author(s) | Year | View Count |
 | Effect of applying the new Clinical and Laboratory Standards Institute ceftazidime and ceftriaxone susceptibility breakpoints for Escherichia coli in Hong Kong | Ho, PL; Chow, KH; Lo, WU; To, KK; Cheng, VC | 2011 | 448 |
| Logistic regression analysis for predicting methicillin-resistant staphylococcus aureus (MRSA) in-hospital mortality | Hai, Y; Cheng, VC; Wong, SY; Tsui, KL; Yuen, KY | 2011 | 93 |
| The natural viral load profile of patients with pandemic 2009 influenza A(H1N1) and the effect of oseltamivir treatment | Li, IW; Hung, IF; To, KK; Chan, KH; Wong, SSY; Chan, JF; Cheng, VC; Tsang, OT; Lai, ST; Lau, YL; Yuen, KY | 2010 | 558 |
| Decreasing prevalence of levofloxacin-resistant Streptococcus pneumoniae in Hong Kong, 2001 to 2007 | Ho, PL; Cheng, VC; Chow, KH | 2009 | 338 |
| Comparative host gene transcription by microarray analysis early after infection of the Huh7 cell line by SARS coronavirus and human coronavirus 229E. | Tang, BS; Chan, KH; Cheng, VC; Yuen, KY | 2009 | 69 |
| Retracted: outcome and immune reconstitution of HBV-specific immunity in patients with reactivation of occult HBV infection after alemtuzumab-containing chemotherapy regimen. | Hui, CK; Cheung, WW; Leung, KW; Cheng, VC; Tang, BS; Li, IW; Luk, JM; Lee, NP; Kwong, YL; Au, WY; Yuen, KY; Lau, GK; Liang, R | 2008 | 55 |
| Mycobacterium tuberculosis sternal wound infection after open heart surgery: a case report and review of the literature | Wang, TK; Wong, CF; Au, WK; Cheng, VC; Wong, SS | 2007 | 125 |
 | A patient with asymptomatic severe acute respiratory syndrome (SARS) and antigenemia from the 2003-2004 community outbreak of SARS in Guangzhou, China. | Che, XY; Di, B; Zhao, GP; Wang, YD; Qiu, LW; Hao, W; Wang, M; Qin, PZ; Liu, YF; Chan, KH; Cheng, VC; Yuen, KY | 2006 | 172 |
| Pulmonary artery thrombosis in a patient with severe acute respiratory syndrome. | Ng, KH; Wu, AK; Cheng, VC; Tang, BS; Chan, CY; Yung, CY; Luk, SH; Lee, TW; Chow, L; Yuen, KY | 2005 | 317 |
|
